| 470
|
依米得韦单抗
|
Research Grade Imdevimab
|
2415933-40-1 |
| 469
|
Research Grade Imaprelimab
|
Research Grade Imaprelimab
|
2014343-04-3 |
| 468
|
Research Grade Iladatuzumab
|
Research Grade Iladatuzumab
|
1906205-76-2 |
| 467
|
Research Grade HuCC49
|
Research Grade HuCC49
|
823788-82-5 |
| 466
|
Research Grade Gosuranemab
|
Research Grade Gosuranemab
|
1788032-39-2 |
| 465
|
Research Grade Gontivimab
|
Research Grade Gontivimab
|
1257358-38-5 |
| 464
|
Research Grade Golimumab
|
Research Grade Golimumab
|
476181-74-5 |
| 463
|
Research Grade Gimsilumab
|
Research Grade Gimsilumab
|
1648796-29-5 |
| 461
|
Research Grade Faricimab
|
Research Grade Faricimab
|
1607793-29-2 |
| 460
|
Research Grade Etigilimab
|
Research Grade Etigilimab
|
2044984-83-8 |
鄂公网安备42011102005485号 